Cargando…

Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial

Early insertion of a supraglottic airway (SGA) device could improve chest compression fraction by allowing providers to perform continuous chest compressions or by shortening the interruptions needed to deliver ventilations. SGA devices do not require the same expertise as endotracheal intubation. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuby, Loric, Jampen, Laurent, Sierro, Julien, Bergeron, Maxime, Paus, Erik, Spichiger, Thierry, Suppan, Laurent, Thurre, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745715/
https://www.ncbi.nlm.nih.gov/pubmed/35011958
http://dx.doi.org/10.3390/jcm11010217
_version_ 1784630412500271104
author Stuby, Loric
Jampen, Laurent
Sierro, Julien
Bergeron, Maxime
Paus, Erik
Spichiger, Thierry
Suppan, Laurent
Thurre, David
author_facet Stuby, Loric
Jampen, Laurent
Sierro, Julien
Bergeron, Maxime
Paus, Erik
Spichiger, Thierry
Suppan, Laurent
Thurre, David
author_sort Stuby, Loric
collection PubMed
description Early insertion of a supraglottic airway (SGA) device could improve chest compression fraction by allowing providers to perform continuous chest compressions or by shortening the interruptions needed to deliver ventilations. SGA devices do not require the same expertise as endotracheal intubation. This study aimed to determine whether the immediate insertion of an i-gel(®) while providing continuous chest compressions with asynchronous ventilations could generate higher CCFs than the standard 30:2 approach using a face-mask in a simulation of out-of-hospital cardiac arrest. A multicentre, parallel, randomised, superiority, simulation study was carried out. The primary outcome was the difference in CCF during the first two minutes of resuscitation. Overall and per-cycle CCF quality of compressions and ventilations parameters were also compared. Among thirteen teams of two participants, the early insertion of an i-gel(®) resulted in higher CCFs during the first two minutes (89.0% vs. 83.6%, p = 0.001). Overall and per-cycle CCF were consistently higher in the i-gel(®) group, even after the 30:2 alternation had been resumed. In the i-gel(®) group, ventilation parameters were enhanced, but compressions were significantly shallower (4.6 cm vs. 5.2 cm, p = 0.007). This latter issue must be addressed before clinical trials can be considered.
format Online
Article
Text
id pubmed-8745715
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87457152022-01-11 Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial Stuby, Loric Jampen, Laurent Sierro, Julien Bergeron, Maxime Paus, Erik Spichiger, Thierry Suppan, Laurent Thurre, David J Clin Med Article Early insertion of a supraglottic airway (SGA) device could improve chest compression fraction by allowing providers to perform continuous chest compressions or by shortening the interruptions needed to deliver ventilations. SGA devices do not require the same expertise as endotracheal intubation. This study aimed to determine whether the immediate insertion of an i-gel(®) while providing continuous chest compressions with asynchronous ventilations could generate higher CCFs than the standard 30:2 approach using a face-mask in a simulation of out-of-hospital cardiac arrest. A multicentre, parallel, randomised, superiority, simulation study was carried out. The primary outcome was the difference in CCF during the first two minutes of resuscitation. Overall and per-cycle CCF quality of compressions and ventilations parameters were also compared. Among thirteen teams of two participants, the early insertion of an i-gel(®) resulted in higher CCFs during the first two minutes (89.0% vs. 83.6%, p = 0.001). Overall and per-cycle CCF were consistently higher in the i-gel(®) group, even after the 30:2 alternation had been resumed. In the i-gel(®) group, ventilation parameters were enhanced, but compressions were significantly shallower (4.6 cm vs. 5.2 cm, p = 0.007). This latter issue must be addressed before clinical trials can be considered. MDPI 2021-12-31 /pmc/articles/PMC8745715/ /pubmed/35011958 http://dx.doi.org/10.3390/jcm11010217 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Stuby, Loric
Jampen, Laurent
Sierro, Julien
Bergeron, Maxime
Paus, Erik
Spichiger, Thierry
Suppan, Laurent
Thurre, David
Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial
title Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial
title_full Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial
title_fullStr Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial
title_full_unstemmed Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial
title_short Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial
title_sort effect of early supraglottic airway device insertion on chest compression fraction during simulated out-of-hospital cardiac arrest: randomised controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745715/
https://www.ncbi.nlm.nih.gov/pubmed/35011958
http://dx.doi.org/10.3390/jcm11010217
work_keys_str_mv AT stubyloric effectofearlysupraglotticairwaydeviceinsertiononchestcompressionfractionduringsimulatedoutofhospitalcardiacarrestrandomisedcontrolledtrial
AT jampenlaurent effectofearlysupraglotticairwaydeviceinsertiononchestcompressionfractionduringsimulatedoutofhospitalcardiacarrestrandomisedcontrolledtrial
AT sierrojulien effectofearlysupraglotticairwaydeviceinsertiononchestcompressionfractionduringsimulatedoutofhospitalcardiacarrestrandomisedcontrolledtrial
AT bergeronmaxime effectofearlysupraglotticairwaydeviceinsertiononchestcompressionfractionduringsimulatedoutofhospitalcardiacarrestrandomisedcontrolledtrial
AT pauserik effectofearlysupraglotticairwaydeviceinsertiononchestcompressionfractionduringsimulatedoutofhospitalcardiacarrestrandomisedcontrolledtrial
AT spichigerthierry effectofearlysupraglotticairwaydeviceinsertiononchestcompressionfractionduringsimulatedoutofhospitalcardiacarrestrandomisedcontrolledtrial
AT suppanlaurent effectofearlysupraglotticairwaydeviceinsertiononchestcompressionfractionduringsimulatedoutofhospitalcardiacarrestrandomisedcontrolledtrial
AT thurredavid effectofearlysupraglotticairwaydeviceinsertiononchestcompressionfractionduringsimulatedoutofhospitalcardiacarrestrandomisedcontrolledtrial